Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages

Pharmaceutical Drug Roundup Inside A Pharmacy

Health Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages Influential proxy firm ISS on Monday turned up the heat on Mylan myl , advising its institutional clients to voice their dissatisfaction with the generic drugmaker’s board of directors and

Coal Inspection And Testing At The Central Geological Laboratory

Finance Scientific Instrument Giant Thermo Fisher to Buy Patheon for About $5.2 Billion Thermo Fisher Scientific, the world’s No. 1 maker of scientific instruments, said on Monday it would buy Dutch drug ingredients maker Patheon as it looks to become a one-stop shop for contract

Health These Two Drug Companies Want to Legally Block Executions in Arkansas Arkansas has plans to execute seven death row inmates in fewer than two weeks this month. But two drug makers are trying to make sure their products play no part in the process, which has been

Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion

Finance Abbott Finally Agrees to Buy Alere After Cutting the Price to $4.5 Billion Diversified healthcare company Abbott Laboratories on Friday agreed to buy Alere for about $4.48 billion, ending a prolonged legal battle over its plan to buy the diagnostic-testing company.

The American Enterprise Institute photo of Scott Gottlieb

Health Trump Is Slashing FDA Rules. Why Isn’t Big Pharma Excited?President Donald Trump is planning to take the ax to Food and Drug Administration regulations. “[We’re] going to be streamlining the process so that, from your standpoint, when you have a drug, you

Health An FDA Program Incentivizing Rare Disease Drugs Will Be Investigated for Abuses In late 1982, Congress overwhelmingly passed the Orphan Drug Act, which was then signed into law by President Ronald Reagan on January 4, 1983 – a long overdue New Year’s present for the

Pharmaceutical Production Inside Merck KGaA Health Care Laboratory

Health Pharma Executives Aren’t Excited About Trump’s Plans to Ease FDA Regulation U.S. President Donald Trump’s vow to roll back government regulations at least 75% is causing anxiety for some pharmaceutical executives that a less robust Food and Drug Administration would

Health These Were Big Pharma’s Biggest Winners and Losers in 2016 Biopharma stocks endured a precipitous decline over the course of 2016. But some giants drug making giants made out far better than others, according to a new report based on data from analytics firm

Health Johnson & Johnson Is Dialing Down Crazy Drug Price Hikes Is the pharmaceutical industry finally ditching its price gouging ways? Well, sort of, depending on who you ask. On Monday, drug giant Johnson & Johnson jnj pulled the curtain back on its own

Leadership Democrats Must Overhaul Party, Attack Big Business, Sanders Says Former U.S. Democratic presidential candidate Bernie Sanders on Sunday urged a major overhaul of his party, calling for more aggressive efforts to court working-class voters and fight big businesses

CEO Daily NewsletterSign up for CEO Daily to get must-read business news fit for the corner office—plus more.View Sample

Most Popular on FORTUNE

China confronts its Lehman moment

Joe Biden Responds to Bill Ackman: ‘Who Is This Asshole?’

Windows 10 Source Code Leaked

Microsoft Corp. Launches Windows 10 In Japan

Windows 10 Source Code Leaked

Costco Stock Suffers Massive Slide after Amazon-Whole Foods Deal

Obama’s Response to Russian Hacking: Limited, Cautious, and Frustrated

Obama Holds Bilateral Meeting With Russian President Putin At UN

Obama’s Response to Russian Hacking: Limited, Cautious, and Frustrated

Customer Service Site Map Privacy Policy Advertising Ad Choices Terms of Use Your California Privacy Rights Careers

All products and services featured are based solely on editorial selection. FORTUNE may receive compensation for some links to products and services on this website.

Quotes delayed at least 15 minutes. Market data provided by Interactive Data. ETF and Mutual Fund data provided by Morningstar, Inc. Dow Jones Terms & Conditions: http://www.djindexes.com/mdsidx/html/tandc/indexestandcs.html. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions